<DOC>
	<DOC>NCT01798160</DOC>
	<brief_summary>Selective Internal Radiation Therapy is superior to Transarterial Chemoembolisation for the treatment of intermediate stage hepatocellular carcinoma.</brief_summary>
	<brief_title>Selective Internal Radiation Therapy (SIRT) Versus Transarterial Chemoembolisation (TACE) for the Treatment of Hepatocellular Carcinoma (HCC).</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma, Hepatocellular</mesh_term>
	<criteria>≥18 years HCC, proven by histology or according to EASL criteria Intermediate stage HCC (stage B according to BCLC) At least one measurable lesion in magnetic resonance imaging (MRI) Tumor load ≤ 50% preserved liver function (Child Pugh A and B) Patients feasible for curative treatment (e.g. resection or local ablation) Previous TACE or SIRT Chemotherapy during the last 4 weeks Child Pugh stage C BCLC stage D ECOG Performance Status &gt;0 Tumor involvement &gt;50% of the liver Extrahepatic tumor Serum Bilirubin &gt;2.0 mg/dl; Serum Albumin 2.8 g/dl, Serum Creatinine &gt;2 mg/dl; Leukocytes &lt;3000/ml; Thrombocytes &lt;50000/ml Clinically apparent ascites (ascites only in CT/MRI is no exclusion criteria) Esophageal bleeding during the last 3 months Hepatic encephalopathy Transjugular intrahepatic portosystemic shunt (TIPS) Infiltration or occlusion of the portal vein Hepatofugal blood flow in the portal vein Hepatopulmonary shunt ≥ 20% in the macroaggregated albumin scan Contraindications against angiography Gravidity</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>